Management of meningitis due to antibiotic-resistant Acinetobacter species
- 1 April 2009
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 9 (4) , 245-255
- https://doi.org/10.1016/s1473-3099(09)70055-6
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- An increasing threat in hospitals: multidrug-resistant Acinetobacter baumanniiNature Reviews Microbiology, 2007
- Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC ProgramDiagnostic Microbiology and Infectious Disease, 2006
- Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)Diagnostic Microbiology and Infectious Disease, 2006
- Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA)Diagnostic Microbiology and Infectious Disease, 2006
- Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomiesDiagnostic Microbiology and Infectious Disease, 2006
- An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004Diagnostic Microbiology and Infectious Disease, 2005
- Use of a program-specific website to disseminate surveillance data obtained from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) StudyDiagnostic Microbiology and Infectious Disease, 2005
- Susceptibility of meropenem and comparators tested against 30,634 enterobacteriaceae isolated in the MYSTIC programme (1997–2003)Diagnostic Microbiology and Infectious Disease, 2004
- Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal FluidClinical Pharmacokinetics, 2000
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995